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Myofibroblastoma (MFB) of the breast is an uncommon entity of benign spindle 
neoplasms of the breast. This tumour possesses a broad spectrum of 
histomorphological patterns. Distinguishing of myofibroblastoma variants from 
malignant mimics of this benign neoplasm is essential for pathologists to avoid 
further invasive surgical procedures. In this article, we report the clinical, 
morphological, and immunohistochemical features of three cases, including two 
females and one male patient with mammary myofibroblastoma with emphasis on 
the histomorphological findings. As there is not yet enough information about MFB, 
more reports of MFB are still required to more clarify the pathogenesis and potential 
predisposing factors of this rare type of breast tumours. 
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Mammary myofibroblastoma (MFB) is an 
uncommon type of benign spindle stromal tumours 
described to occur in the breast (1). Sixteen cases 
were first described by Wargotz et al. in 1987 (2). The 
first case series was reported mostly in male patients; 
however, subsequent case reports revealed the 
occurrence of the tumour in females as well as male 
patients (1-4). In recent decades, the incidence of 
MFB has been raised, which can be due to the 
increased use of imaging techniques for screening 
purposes. MFB has been suggested to arise from 
mammary stromal fibroblasts with positivity for 
CD34 and vimentin markers. On the other hand, 
expression of ER, PR and AR receptors in these cells 
guided us to a probable role of sex steroid hormones 
in their pathogenesis (5). Myofibroblast cells are 
capable of multidirectional mesenchymal 
differentiation, which can further differentiate into 
smooth muscle, cartilage, or osseous tissue (1). 
Differential diagnoses of myofibroblastoma are 
benign conditions including reactive processes and 
benign neoplasms such as nodular and proliferative 
fasciitis, spindle cell lipoma, neurofibroma and 
leiomyoma. More-over, low-grade malignant 
sarcomas such as spindle cell liposarcoma, low grade 
myofibroblastic sarcoma, and metaplastic spindle cell 
carcinoma also encompass the differential diagnoses 
of MFB (6). 
Various morphologic variants of myofibroblastoma 
may be misdiagnosed as malignant neoplasms such as 
stromal sarcoma, high grade undifferentiated 
pleomorphic sarcoma and spindle or metaplastic 
carcinoma; there-fore, pathologists must be able to 
distinguish myofibroblastoma from other malignant 
mimickers and avoid over-diagnosing the malignant 
lesions and unnecessary invasive interventions. Herein, 
we report 3 cases of mammary MFB in one male 
patient and 2 female patients from three tertiary referral 
centres in southern and northern Iran. 
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A 52-year-old woman was referred to “Shariati 
hospital, Tehran, Iran” due to a palpable lump in the 
right mammary region, she was otherwise healthy. 
Lumpectomy was done on one ovoid piece of well-
demarcated unencapsulated soft tissue measuring 
2.5x2.3x1.2 cm with a rubbery consistency. Cut 
sections of the specimen revealed a pinkish whorling 
pattern. Tumour tissue was fixed in formalin, and slides 
from paraffin blocks were stained with haematoxylin-
eosin (H&E). The histomorphological study revealed a 
neoplasm with pushing border composed of ovoid to 
elongated cells with mild to moderate amount of 
eosinophilic cytoplasm, arranged in fascicles. Some 
multinucleated floret-like giant cells were observed. 
Deposition and myxoid degeneration were present in 
between areas of collagen. Mitotic activity was nil and 
entrapped breast ductal, and lobar structures were also 
identified (Figure 1). 
Immunohistochemical studies revealed various 
tumour cells positive for progesterone receptor (PR), 
smooth muscle actin (SMA), CD34, and CD10. Ki-67 




Fig. 1. Myofibroblastoma, Collagenous/fibrous variant. 
Hypocellular neoplasm with a densely hyalinized stroma. 
Entrapped breast ductal and lobular structures are noted. 




Fig. 2. Immunohistochemical staining for progesterone 
receptor (PR) [left] and CD10 [right], (100X magnification) 
 
Case 2 
A 75-year-old male was referred to “Sina Hospital, 
Tehran, Iran”, presenting with a long-lasting history of 
unilateral left-sided gynecomastia without nipple 
discharges or retractions and had no family history of 
cancer. Examining the patient, a round palpable mass was 
detected in his left breast region. Surgical excision was 
performed with 1 cm free surgical margins. On gross 
examination, a round greyish well-circumscribed mass 
with a firm consistency and homogenous cut surfaces was 
detected. Histological sections showed a hypercellular 
spindle neoplasm composed of haphazardly arranged and 
occasionally intersecting fascicles of bland-looking 
spindle shape tumour cells having hyperchromatic nuclei, 
inconspicuous nucleoli, and eosinophilic cytoplasm. 
Occasional palisading and ropey-like collagen deposition 
were identified. No necrosis, atypia or mitosis were 
confirmed (Figures 4 and 5). 
Immunohistochemical study showed positivity of 
tumoral cells for desmin, CD34, and progesterone 
receptor (PR) (Figure 5).  
 
 
Fig. 3. Myofibroblastoma, Classic variant, Histologic 
sections demonstrate haphazardly arranged rather bland-
looking spindle shape tumoral cells. Haematoxylin and Eosin 
(H&E), (40X magnification).
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Fig. 4. A dense neoplastic area composed mainly of neoplastic 
cells with fibroblast-like appearance that intermingled with 
collagen bundles. Haematoxylin and Eosin (H&E), (400X 
magnification) 
 
Fig 5. IHC staining for CD34, desmin, Progesterone receptor 
(PR), and α-Smooth muscle actin (SMA), (400X magnification) 
Case 3 
The patient was a 55-year-old female who referred 
to “Nemazee hospital, Shiraz, Iran” with a chief 
complaint of left breast mass, which gradually 
enlarged. The intervention was done to surgically 
remove the mentioned mass. On gross examination, the 
tumour was a grey-white rubbery well-circumscribed 
tissue measuring 3 x 2.5 x 2 cm. Histopathology 
sections demonstrated a fascicular arrangement of 
tumoral cells with the bland-looking spindle-shaped 
appearance admixed with hyalinized collagen bundles 
with areas of myxoid changes (Figures 6 and 7).  
On immunohistochemical staining, tumoral cells 
were positive for CD34, and focally positive for 




Fig 6. Fascicles of spindled cells with stromal hyaline depositions. 
Haematoxylin and Eosin (H&E), (40X magnification) 
 
 
Fig 7. Myofibroblastoma with myxoid change plump-spindle 
shaped tumoral cells intermingled with collagen bundles. 
Haematoxylin and Eosin (H&E), (400X magnification) 
 
Discussion  
The entity of MFB was first introduced by Toker et 
al. in 1981 (7), years later in 1987, the term 
“myofibroblastoma” was reported by Wargotz et al. 
(2). The first reports showed a male predilection, 
however, subsequent reports showed occurrence of 
MFB in both genders. Most cases are diagnosed in men 
and postmenopausal women. MFB has been known to 
be sporadic, but in some patients, it has been diagnosed 
in the setting of gynecomastia. In our study, the second 
case presentation, the tumour was found in a patient 
with gynecomastia (8, 9). MFB is currently ranked in 
the category of benign mesenchymal tumours with 
deletion of 13q14 region, which has been seen either in 
spindle cell lipoma or cellular angiofibroma (10).  
Grossly, MFB is reported as an unencapsulated 
round, oval, or lobulated mass with firm and rubbery 
consistency. Cut surfaces are white to greyish with 
whirling homogeneous appearance (1). All our cases 
were oval masses with rubbery consistency. 
Histomorphologically, MFB is a purely mesen-
chymal tumour composed of bland-looking spindle 
cells, which is interspersed with hyalinized collagen 
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fibers, and sometimes foci of infiltration at the 
periphery which may entrap benign breast glands and 
adipocyte tissue (11). The tumour also shows low 
proliferative activity, without atypia and necrosis. 
Several histologic variants are mainly due to the 
capacity of myofibroblasts to multidirectional mesen-
chymal differentiation. At least eight histologic var-
iants of MFB have been discussed in the literature, 
including classic-type, cellular, infiltrative, epithelioid, 
desidualoid-like, collagenised/fibrous, lipomatous, and 
myxoid variants (1, 11). In our study, the first case was 
categorised in collagenized/fibrous variant, in which 
spindle cells are seen in a dense collagenized stroma. 
Collagen fibers formed slit-like spaces (Figure 1). The 
second case was a typical classic-type of myofibro-
blastoma composed of bland-looking haphazardly 
intersecting spindle cells admixed with hyalinized 
collagen bundles (Figure 3, 4). The third case showed 
myxoid changes. (Figure 6, 7) 
MFB may be misdiagnosed as malignancy 
depending on the clinical setting and morphological 
features alone. Therefore, Immunohistochemistry 
plays an essential role in the establishment of final 
diagnosis, especially regarding unusual variants. 
According to literature, most of the cases are positive 
for mesenchymal markers such as vimentin, CD34, and 
desmin (1). Variable expressions of smooth muscle 
actin, BCL2 and CD99 have been reported, and most 
of the reported tumours were positive for estrogen, 
progesterone receptor, and androgen receptor.  
In our first case presentation, IHC staining for 
CD34, SMA, BCL2 and Progesterone receptor were 
positive. (Figure 2) CD10 was also positive in some 
tumoral cells, which is consistent with the previous 
studies and has been regarded as an evidence of linking 
between mammary myofibroblastoma and spindle cell 
lipoma of soft tissue (12). S100, and cytokeratin did not 
stain tumoral cells, which is consistent with the 
previous reports (1). Other markers which were 
negative included desmin, beta-catenin, CD68, 
estrogen receptor, and CD99. Ki67 stained about 1 
percent of tumoral cells. Second case was positive for 
desmin, CD34, and progesterone receptor. Tumoral 
cells also showed weakly positivity for estrogen 
receptor. (Figure 5) S100, SMA, BCL2, Caldesmon 
were negative in spindle tumoral cells and Ki 67 
showed 1% proliferative index. The third case showed 
positivity for CD34 and focal positivity of estrogen 
receptor. Markers of CD68, HMB45, vimentin, 
Cytokeratin, and CD31 were negative. Ki 67 was 
positive in less than 1% of tumour cells. 
 
Conclusion  
In conclusion, more reports of MFB are still 
required to more clarify the pathogenesis and potential 
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